Related Experiment Videos
Alveolar macrophage status in bronchopulmonary dysplasia
A Clement1, K Chadelat, A Sardet
1Pulmonary Department of Pediatrics, Hospital Trousseau, Paris, France.
Abstract:
The predominant inflammatory cell type within the alveolar structure in bronchopulmonary dysplasia (BPD) is the alveolar macrophage (AM). AM ability to release hydrogen peroxide, a way to evaluate the cell status, was studied in nine infants who developed clinical and radiological evidence of BPD, and was compared to those from infants without lung parenchymal disorders (n = 6). AM were collected by bronchoalveolar lavage which was done after the mechanical ventilation stage in the BPD group. The experiments were performed on unstimulated AM and on AM stimulated by phorbol myristate acetate. Results revealed that the amount of hydrogen peroxide accumulated in the culture medium was significantly enhanced in the BPD group, in both experimental conditions (p less than 0.01 and less than 0.001, respectively). Furthermore, improvement of patients treated with glucocorticoids was closely related to a reduction of the alveolitis with a decrease of AM ability to generate hydrogen peroxide. These data indicate that AM activation is a central component of alveolitis in BPD and that extracellular production of oxidants by stimulated AM may play a critical role in the pathogenesis of the disease.
Insights
Alveolar macrophages (AMs) in infants with bronchopulmonary dysplasia (BPD) show heightened hydrogen peroxide release, indicating increased activation. This suggests AMs play a key role in BPD pathogenesis and alveolitis.
Area of Science:
- Pulmonary Medicine
- Immunology
- Neonatology
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants.
- Alveolar macrophages (AMs) are the primary inflammatory cells in BPD alveoli.
- AMs' hydrogen peroxide (H2O2) release indicates cellular activation status.
Purpose of the Study:
- To investigate AM H2O2 release in infants with BPD.
- To compare AM function in BPD infants versus healthy controls.
- To explore the relationship between AM activation and BPD severity/treatment.
Main Methods:
- Bronchoalveolar lavage (BAL) collected AMs from BPD infants and controls.
- AMs were tested for H2O2 release, both unstimulated and stimulated (phorbol myristate acetate).
- H2O2 levels in culture medium were quantified.
Main Results:
- Significantly enhanced H2O2 accumulation in AMs from BPD infants under both conditions (p<0.01, p<0.001).
- Glucocorticoid treatment correlated with reduced alveolitis and decreased AM H2O2 generation.
- AM activation and oxidant production are linked to BPD pathogenesis.
Conclusions:
- AM activation is a central feature of alveolitis in BPD.
- Extracellular oxidant production by activated AMs may contribute to BPD development.
- Targeting AM activation could be a therapeutic strategy for BPD.